Evidence map›Paper›PMID 26827836›Full record

ArticleVeterinary immunology and immunopathology2016

Immunologic progression of canine leishmaniosis following vertical transmission in United States dogs.

Blake Vida, Angela Toepp, Robert G Schaut, Kevin J Esch, Rachel Juelsgaard, Raeann M Shimak, Christine A Petersen

Abstract read
In one paragraph

Article in Veterinary immunology and immunopathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Possibility ofCurrent tropical medicine reports · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The balancing act: Immunology of leishmaniosis.Research in veterinary science · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Safety Analysis ofThe American journal of tropical medicine and hygiene · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Blake VidaDepartment of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, Iowa, 50011, USA.
Angela ToeppDepartment of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA.
Robert G SchautDepartment of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA.
Kevin J EschDepartment of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, Iowa, 50011, USA.
Rachel JuelsgaardDepartment of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, Iowa, 50011, USA.
Raeann M ShimakDepartment of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, Iowa, 50011, USA.
Christine A PetersenDepartment of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA; Immunology Program, University of Iowa, Iowa City, IA 52242, USA. Electronic address: christine-petersen@uiowa.edu.
Iowa State University · USUniversity of Iowa · US

Funding

Role of pathogen-derived capping carbohydrates in altering immunityR21AI074711 · NIAID · IOWA STATE UNIVERSITY · PI PETERSEN, CHRISTINE A · 2008 to 2010
$491k
Sand fly role in transmission of CVL in North AmericaR21AI088051 · NIAID · KANSAS STATE UNIVERSITY · PI RAMALHO-ORTIGAO, JOSE MARCELO · 2010 to 2011
$414k
NIAID NIH HHS R21 AI074711NIAID NIH HHS R21AI074711NIAID NIH HHS R21 AI088051
6 · The paper itself

Abstract

Canine leishmaniosis (CanL) is caused by Leishmania infantum, an obligate intracellular protozoan parasite, endemic in U.S. hunting dog populations. CanL has been found in dogs in 28 states and two Canadian provinces. Previous studies by our group, (Boggiatto et al., 2011), demonstrated that vertical transmission of Leishmania was the predominant means of transmission within U.S. dogs. Very little is known regarding how this alternative means of transmission, alters the long-term immunity and clinical presentation of leishmaniosis in dogs born to a positive bitch. This study follows the immunological progression of CanL in three pups after birth to an infected bitch. During the course of the study, these dogs were tested every six months over the course of six years. Both immunologic (IFN-γ, T cell proliferation, antibody production) and parasitological parameters (qPCR) of vertically-infected dogs were measured. Within the six years after birth to an L. infantum-infected, oligosymptomatic bitch, all dogs had at least one L. infantum PCR-positive test. Interestingly, despite living in the same location for their entire lives and being full siblings, these pups demonstrate three different disease progression patterns of L. infantum infection. One dog progressed to oligosymptomatic disease, maintaining a positive titer and had intermittent positive PCR results. One asymptomatic dog had positive serological titers and demonstrated a robust CD4(+) immune response to infection. The third dog had a negligible response to L. infantum antigen and was healthy. This work demonstrates the biologic variability associated with vertically-transmitted infection similar to the variety of presentations observed during vector-borne leishmaniosis.

Indexed as

AnimalsDisease ProgressionDog DiseasesDogsFemaleLeishmania infantumLeishmaniasis, VisceralMalePregnancyPregnancy Complications, ParasiticUnited StatesCanineImmune responseLeishmaniasisProgressionqPCRSerologyVertical transmission

Identifiers

PMID26827836
PMCPMC4799997
OpenAlexW2185665142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.